comparemela.com
Home
Live Updates
Shankar Musunuri Co - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Shankar musunuri co - Page 1 : comparemela.com
Ocugen (OCGN) Q4 2023 Earnings Call Transcript
OCGN earnings call for the period ending March 31, 2024.
Daniil gataulin
Swayampakula ramakanth
Swayampakula hc wainwright
Shankar musunuri
Daniil gataulin chardan
Michael breininger
Tiffany hamilton head of corporate communications
Company analyst
Exchange commission
Shankar musunuri co
Tiffany hamilton
Huma qamar
Private securities litigation reform act
Risk factors
Chief executive
Project nextgen
Ocugen (OCGN) Q4 2023 Earnings Call Transcript
OCGN earnings call for the period ending March 31, 2024.
Shankar musunuri
Swayampakula ramakanth
Michael breininger
Swayampakula hc wainwright
Daniil gataulin
Daniil gataulin chardan
Exchange commission
Shankar musunuri co
Company analyst
Tiffany hamilton head of corporate communications
Tiffany hamilton
Huma qamar
Motley fool stock advisor
Stock advisor
Private securities litigation reform act
Risk factors
Ocugen (OCGN) Q3 2023 Earnings Call Transcript
OCGN earnings call for the period ending September 30, 2023.
United states
Tarun upadhyay
Michael breininger
Shankar musunuri
Robert leboyer
Tiffany hamilton head of corporate communications
Shankar musunuri co
Exchange commission
National institute of allergy
Head of research
Company analyst
Tiffany hamilton
Motley fool stock advisor
Stock advisor
Private securities litigation reform act
Risk factors
Ocugen (OCGN) Q2 2023 Earnings Call Transcript
OCGN earnings call for the period ending June 30, 2023.
Jen kim cantor fitzgerald
Jennifer kim
Daniil gataulin chardan
William ramakanth
Tarun upadhyay
Shankar musunuri
Daniil gataulin
A nuclear
Shankar musunuri co
Association for research
Tiffany hamilton head of corporate communications
Exchange commission
Cantor fitzgerald
Tiffany hamilton
Private securities litigation reform act
Motley fool stock advisor
Ocugen (OCGN) Q1 2023 Earnings Call Transcript
OCGN earnings call for the period ending March 31, 2023.
United states
Jennifer kim cantor fitzgerald
Quan vu
Shankar musunuri
Swayampakula ramakanth
Jonathan aschoff
Robert leboyer
Daniil gataulin
Jennifer kim
Daniil gataulin chardan
Swayampakula hc wainwright
Sharon choe
Shankar musunuri co
Drug administration
Company analyst
Cantor fitzgerald
vimarsana © 2020. All Rights Reserved.